Clinical Trial

Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to collect clinical data on patient outcomes, evaluate the safety and performance of Ankura TAA Stent Graft System and Surpass Super Stiff Guidewire, and build clinical evidence for patients with Descending Thoracic Aneurysm (DTA) or Type B Aortic Dissection (TBAD).
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2022-12-05; most recent amendment 2026-05-21.
Status change: Recruiting → Active, Not Recruiting 2026-05-21
Status change: Not Yet Recruiting → Recruiting 2023-02-02
Trial Details
NCT Number NCT05639569
Lead Sponsor Lifetech Scientific (Shenzhen) Co., Ltd.
Conditions Aneurysm Thoracic, Dissection of Thoracic Aorta
Enrollment 147 participants
Start Date 2023-05-03
Primary Completion 2026-12-30 (estimated)
Study Completion 2030-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-26